See more : BRIM Biotechnology, Inc. (6885.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Patrys Limited (PAB.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Patrys Limited, a leading company in the Biotechnology industry within the Healthcare sector.
- Jiangsu Lidao New Materials Co., Ltd. (603937.SS) Income Statement Analysis – Financial Results
- D&D Pharmatech (347850.KQ) Income Statement Analysis – Financial Results
- KnowBe4, Inc. (KNBE) Income Statement Analysis – Financial Results
- Yinhang Internet Technologies Development, Inc. (YITD) Income Statement Analysis – Financial Results
- Carbon Minerals Limited (CRM.AX) Income Statement Analysis – Financial Results
Patrys Limited (PAB.AX)
About Patrys Limited
Patrys Limited, together with its subsidiaries, develops and commercializes antibody technologies for the treatment of cancer in Australia. Its lead technology is Deoxymab 3E10, a DNA damage-repair antibody that penetrates cell nuclei. The company also focuses on developing PAT-DX1, an antibody fragment for the treatment of primary and secondary brain cancer. In addition, it is developing PAT-DX3, a full-sized antibody that has DNA-binding and DNA damage repair blocking properties of PAT-DX1 used for tissue distribution, pharmacokinetic profile, etc.; and PAT-DX1-NP, a product based on the targeted delivery of nanoparticles carrying therapeutic payloads to the inside of cancer cells. The company was incorporated in 2006 and is based in Melbourne, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.39M | 2.85M | 27.50K | 27.50K | 27.50K | 844.37K | 520.53K | 53.26K | 274.97K | 2.22M | 759.68K | 2.64K | 4.85K | 7.60K | 4.65K | 3.74K | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 46.99K | -3.31M | -1.31M | -745.34K | 0.00 | 0.00 | -478.47K | -592.68K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.39M | 2.80M | 3.33M | 1.34M | 772.84K | 844.37K | 520.53K | 531.73K | 867.65K | 2.22M | 759.68K | 2.64K | 4.85K | 7.60K | 4.65K | 3.74K | 0.00 | 0.00 |
| Gross Profit Ratio | 100.00% | 98.35% | 12,122.09% | 4,866.83% | 2,810.34% | 100.00% | 100.00% | 998.31% | 315.54% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% |
| Research & Development | 3.07M | 7.52M | 9.57M | 3.35M | 1.37M | 1.69M | 1.31M | 1.27M | 1.04M | 4.67M | 6.30M | 3.30M | 4.83M | 6.30M | 6.98M | 9.10M | 5.62M | 0.00 |
| General & Administrative | 1.86M | 2.39M | 2.03M | 2.54M | 2.15M | 2.57M | 1.71M | 1.15M | 954.75K | 1.03M | 1.74M | 1.40M | 1.34M | 1.95M | 2.06M | 2.14M | 2.74M | 0.00 |
| Selling & Marketing | 0.00 | -99.34K | -248.54K | -48.56K | -47.79K | 0.00 | 0.00 | 16.19K | -20.14K | 0.00 | 87.41K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.86M | 2.29M | 1.78M | 2.49M | 2.11M | 2.57M | 1.71M | 1.10M | 934.61K | 1.03M | 1.74M | 1.40M | 1.34M | 1.95M | 2.06M | 2.14M | 2.74M | 0.00 |
| Other Expenses | 0.00 | 2.78M | 3.30M | 1.31M | 685.45K | 3.71M | 459.19K | 1.31M | 839.36K | 2.47M | 582.60K | 950.14K | 858.87K | 703.55K | 1.11M | 2.05M | 1.11M | 0.00 |
| Operating Expenses | 4.93M | 9.81M | 11.35M | 5.84M | 3.47M | 1.26M | 3.02M | 2.37M | 1.98M | 6.31M | 8.59M | 5.35M | 7.95M | 9.26M | 10.13M | 11.90M | 8.36M | 0.00 |
| Cost & Expenses | 4.93M | 9.86M | 11.40M | 5.89M | 3.52M | 1.26M | 3.02M | 2.41M | 2.00M | 10.69M | 8.04M | 5.35M | 7.95M | 9.26M | 10.13M | 11.90M | 8.36M | 0.00 |
| Interest Income | 109.13K | 76.88K | 8.10K | 5.30K | 59.89K | 111.57K | 33.83K | 44.51K | 76.87K | 129.53K | 177.09K | 222.84K | 208.02K | 356.61K | 417.90K | 591.89K | 1.11M | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 222.60K | 2.69K | 4.06K | 1.54K | 0.00 |
| Depreciation & Amortization | 47.00K | 46.99K | 47.55K | 48.56K | 47.79K | 48.31K | 47.83K | 47.55K | 20.14K | 603.58K | 544.80K | 647.13K | 1.78M | 1.01M | 1.09M | 657.56K | 311.08K | 0.00 |
| EBITDA | -3.49M | -9.79M | -11.52M | -5.69M | -3.32M | -3.36M | -2.90M | -1.42M | -1.56M | -2.88M | -7.32M | -4.70M | -6.17M | -6.39M | -6.42M | -7.94M | -6.94M | 0.00 |
| EBITDA Ratio | -250.48% | -344.13% | -41,189.67% | -21,127.20% | -12,531.24% | -398.29% | -470.57% | -4,341.48% | -618.94% | -15.71% | -1,058.42% | -177,662.32% | -127,091.40% | -81,250.91% | -138,050.15% | -213,604.47% | 0.00% | 0.00% |
| Operating Income | -3.54M | -9.86M | -11.37M | -5.86M | -3.49M | -3.41M | -2.50M | -2.36M | -1.72M | -3.48M | -7.28M | -5.34M | -7.95M | -9.25M | -10.12M | -11.90M | -8.67M | 0.00 |
| Operating Income Ratio | -253.85% | -345.77% | -41,362.58% | -21,303.78% | -12,705.02% | -404.01% | -479.76% | -4,430.75% | -626.26% | -156.61% | -958.42% | -202,146.80% | -163,851.35% | -121,760.34% | -217,460.34% | -318,619.81% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.29M | 2.80M | -4.79M | -1.67M | 122.14K | 3.87M | 540.86K | 413.45K | 138.77K | -4.98M | 0.00 | 1.82M | 2.85M | 1.85M | 2.61M | 3.29M | 1.11M | 0.00 |
| Income Before Tax | -4.82M | -9.84M | -11.57M | -5.74M | -3.37M | -411.33K | -2.50M | -1.47M | -1.58M | -8.46M | -7.28M | -3.52M | -5.10M | -7.41M | -7.51M | -8.64M | -7.30M | 0.00 |
| Income Before Tax Ratio | -346.03% | -344.91% | -42,064.04% | -20,859.06% | -12,260.86% | -48.71% | -479.76% | -2,756.21% | -575.80% | -380.47% | -958.42% | -133,281.65% | -105,098.37% | -97,459.34% | -161,438.31% | -231,318.50% | 0.00% | 0.00% |
| Income Tax Expense | -1.29M | -2.78M | -4.79M | -1.67M | -623.20K | -644.30K | -455.21K | -410.16K | -502.48K | 6.89K | 8.16K | 6.46K | 10.57K | 15.74K | 21.78K | 22.59K | 24.94K | 0.00 |
| Net Income | -3.54M | -7.06M | -6.78M | -4.06M | -2.75M | -411.33K | -2.50M | -1.06M | -1.08M | -8.47M | -7.29M | -3.53M | -5.11M | -7.42M | -7.54M | -8.66M | -7.32M | 0.00 |
| Net Income Ratio | -253.85% | -247.61% | -24,655.87% | -14,774.25% | -9,994.69% | -48.71% | -479.76% | -1,986.14% | -393.06% | -380.78% | -959.49% | -133,526.11% | -105,316.24% | -97,666.40% | -161,906.38% | -231,923.40% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | -0.04 | -0.05 | -0.04 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | -0.04 | -0.05 | -0.04 | 0.00 |
| Weighted Avg Shares Out | 2.06B | 2.06B | 1.96B | 1.62B | 1.08B | 1.08B | 941.19M | 780.41M | 743.51M | 727.40M | 631.13M | 551.02M | 340.84M | 247.40M | 205.09M | 180.04M | 170.29M | 168.49M |
| Weighted Avg Shares Out (Dil) | 2.06B | 2.06B | 1.96B | 1.62B | 1.08B | 1.08B | 941.19M | 780.41M | 743.51M | 727.40M | 631.13M | 551.02M | 340.84M | 247.40M | 205.09M | 180.04M | 170.29M | 168.49M |
Source: https://incomestatements.info
Category: Stock Reports